Study Protocol: A randomized controlled trial of suicide risk reduction in the year following jail release (the SPIRIT Trial).


Journal

Contemporary clinical trials
ISSN: 1559-2030
Titre abrégé: Contemp Clin Trials
Pays: United States
ID NLM: 101242342

Informations de publication

Date de publication:
07 2020
Historique:
received: 17 01 2020
revised: 14 03 2020
accepted: 13 04 2020
pubmed: 19 4 2020
medline: 25 9 2021
entrez: 19 4 2020
Statut: ppublish

Résumé

This article describes the protocol for a randomized effectiveness and cost-effectiveness trial of Stanley and Brown's Safety Planning Intervention (SPI) during pretrial jail detention to reduce post-release suicide events (suicide attempts, suicide behaviors, and suicide-related hospitalizations). With 10 million admissions per year and short stays (often days), U.S. jails touch many individuals at risk for suicide, providing an important opportunity for suicide prevention that is currently being missed. This study (N = 800) is the first randomized evaluation of an intervention to reduce suicide risk in the vulnerable year after jail release. Given that roughly 10% of all suicides in the U.S. with known circumstances occur in the context of a criminal legal stressor, reducing suicide risk in the year after arrest and jail detention could have a noticeable impact on national suicide rates. Pretrial jail detainees at risk for suicide were randomized to SPI during jail detention plus post-release phone follow-up or to enhanced Standard Care. Outcomes assessed through 12 months post-release include suicide events, suicide attempts, weeks of active suicide ideation, severity of suicide ideation, time to first event, psychiatric symptoms, functioning, and cost-effectiveness. Methods accommodate short jail stays and maximize trial safety and follow-up in a large sample with severe suicide risk, access to lethal means including substances and firearms, high rates of psychiatric illness, and unstable circumstances. Adequate funding was important to create the infrastructure needed to run this large trial cleanly. We encourage funders to provide adequate resources to ensure clean, well-run trials.

Sections du résumé

PURPOSE
This article describes the protocol for a randomized effectiveness and cost-effectiveness trial of Stanley and Brown's Safety Planning Intervention (SPI) during pretrial jail detention to reduce post-release suicide events (suicide attempts, suicide behaviors, and suicide-related hospitalizations).
BACKGROUND
With 10 million admissions per year and short stays (often days), U.S. jails touch many individuals at risk for suicide, providing an important opportunity for suicide prevention that is currently being missed. This study (N = 800) is the first randomized evaluation of an intervention to reduce suicide risk in the vulnerable year after jail release. Given that roughly 10% of all suicides in the U.S. with known circumstances occur in the context of a criminal legal stressor, reducing suicide risk in the year after arrest and jail detention could have a noticeable impact on national suicide rates.
DESIGN
Pretrial jail detainees at risk for suicide were randomized to SPI during jail detention plus post-release phone follow-up or to enhanced Standard Care. Outcomes assessed through 12 months post-release include suicide events, suicide attempts, weeks of active suicide ideation, severity of suicide ideation, time to first event, psychiatric symptoms, functioning, and cost-effectiveness. Methods accommodate short jail stays and maximize trial safety and follow-up in a large sample with severe suicide risk, access to lethal means including substances and firearms, high rates of psychiatric illness, and unstable circumstances.
CONCLUSION
Adequate funding was important to create the infrastructure needed to run this large trial cleanly. We encourage funders to provide adequate resources to ensure clean, well-run trials.

Identifiants

pubmed: 32304829
pii: S1551-7144(20)30081-1
doi: 10.1016/j.cct.2020.106003
pmc: PMC9236190
mid: NIHMS1815476
pii:
doi:

Types de publication

Clinical Trial Protocol Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

106003

Subventions

Organisme : NIMH NIH HHS
ID : U01 MH106660
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Int J Prison Health. 2013;9(4):169-86
pubmed: 25083160
Psychol Sci. 2009 Mar;20(3):278-83
pubmed: 19207694
J Am Acad Child Adolesc Psychiatry. 2003 Dec;42(12):1524-9
pubmed: 14627890
Contemp Clin Trials. 2013 Sep;36(1):14-24
pubmed: 23707435
Am J Psychiatry. 2004 Sep;161(9):1558-63
pubmed: 15337642
JAMA Psychiatry. 2017 Jun 1;74(6):563-570
pubmed: 28456130
J Consult Clin Psychol. 1992 Dec;60(6):970-3
pubmed: 1460159
Am J Public Health. 2015 Aug;105(8):1570-2
pubmed: 26066951
Psychiatr Serv. 2014 Aug 1;65(8):1012-9
pubmed: 24788454
Suicide Life Threat Behav. 2014 Oct;44(5):537-47
pubmed: 24588679
Am J Public Health. 2012 Mar;102 Suppl 1:S33-7
pubmed: 22390597
Arch Suicide Res. 2011;15(2):160-71
pubmed: 21541862
BMJ. 2001 Jul 21;323(7305):135-8
pubmed: 11463679
Arch Gen Psychiatry. 1987 Jun;44(6):540-8
pubmed: 3579500
Prim Care Companion J Clin Psychiatry. 2003 Aug;5(4):169-174
pubmed: 15213779
Am J Psychiatry. 2011 Dec;168(12):1266-77
pubmed: 22193671
Curr Opin Psychiatry. 2007 Jan;20(1):17-22
pubmed: 17143077
Am J Public Health. 2002 Dec;92(12):1895-9
pubmed: 12453803
Suicide Life Threat Behav. 2016 Dec;46(6):752-761
pubmed: 27038050
Suicide Life Threat Behav. 1990 Fall;20(3):213-24
pubmed: 2238014
J Interpers Violence. 2015 Nov;30(18):3244-66
pubmed: 25395223
J Appl Psychol. 2010 Jan;95(1):201-12
pubmed: 20085417
Lancet. 2012 Mar 17;379(9820):1005-12
pubmed: 22305767
Contemp Clin Trials. 2015 Nov;45(Pt B):147-150
pubmed: 26341724
Psychol Med. 2004 Jan;34(1):163-7
pubmed: 14971637
Issues Ment Health Nurs. 1999 Jan-Feb;20(1):73-89
pubmed: 10196925
BMJ. 2005 Oct 8;331(7520):805
pubmed: 16183654
Psychother Res. 2014;24(2):229-39
pubmed: 24188727
Psychiatr Serv. 2018 Jul 1;69(7):751-759
pubmed: 29656710
Psychol Med. 2012 Jun;42(6):1185-93
pubmed: 22008384
JAMA Psychiatry. 2018 Sep 1;75(9):894-900
pubmed: 29998307
Am J Public Health. 2004 Aug;94(8):1418-24
pubmed: 15284053
Am J Orthopsychiatry. 1994 Jan;64(1):136-49
pubmed: 8147422
Suicide Life Threat Behav. 1996 Spring;26(1):1-7
pubmed: 9173604
Bull World Health Organ. 2008 Sep;86(9):703-9
pubmed: 18797646
Am J Public Health. 2012 Dec;102(12):e67-75
pubmed: 23078476
Subst Abus. 2014;35(1):7-11
pubmed: 24588287
J Psychiatr Res. 2012 Sep;46(9):1174-83
pubmed: 22694906
Med Decis Making. 2010 May-Jun;30(3):314-9
pubmed: 19773582
Int J Law Psychiatry. 2005 Jan-Feb;28(1):43-58
pubmed: 15710448
Psychiatr Serv. 2011 Jun;62(6):679-81
pubmed: 21632740
Am J Psychiatry. 2013 Jan;170(1):71-82
pubmed: 23111499
Prison J. 2015 Sep;95(3):330-352
pubmed: 26508805
J Consult Clin Psychol. 2008 Feb;76(1):72-83
pubmed: 18229985
Assessment. 2004 Dec;11(4):330-41
pubmed: 15486169
J Clin Psychol. 2011 Jun;67(6):609-23
pubmed: 21374597
Int J Law Psychiatry. 1999 May-Aug;22(3-4):301-22
pubmed: 10457926
Psychol Assess. 2012 Mar;24(1):197-215
pubmed: 21928908
Br J Psychiatry. 1990 Dec;157:871-6
pubmed: 2289097
Public Health Rep. 2001 May-Jun;116(3):191-6
pubmed: 12034907
J Offender Rehabil. 2008 Jul 1;47(3):290-318
pubmed: 19809591
Contemp Clin Trials. 2017 Apr;55:39-46
pubmed: 28185995
Suicide Life Threat Behav. 2005 Aug;35(4):425-35
pubmed: 16184697
Am J Psychiatry. 2007 Jul;164(7):1035-43
pubmed: 17606655
Int J Law Psychiatry. 2005 May-Jun;28(3):207-21
pubmed: 15950281
Lancet. 2006 Jul 8;368(9530):119-23
pubmed: 16829295
Med Care. 2004 Sep;42(9):927-37
pubmed: 15319619
Indian J Psychiatry. 2011 Jul;53(3):244-8
pubmed: 22135444
Health Serv Res. 2000 Oct;35(4):885-904
pubmed: 11055454
Psychol Methods. 2002 Mar;7(1):83-104
pubmed: 11928892
Psychiatr Serv. 2004 Apr;55(4):373-5
pubmed: 15067147
Addiction. 2010 Mar;105(3):466-75
pubmed: 20402990
BMJ. 2006 May 27;332(7552):1241-5
pubmed: 16735333
J Subst Abuse. 2001;13(3):291-301
pubmed: 11693453
Aust N Z J Public Health. 2004 Feb;28(1):32-6
pubmed: 15108744
Am J Community Psychol. 2010 Dec;46(3-4):361-75
pubmed: 20865315
Behav Sci Law. 1997 Autumn;15(4):383-97
pubmed: 9433744
Psychiatry Res. 2017 Dec;258:189-193
pubmed: 28865719
J Am Acad Psychiatry Law. 2006;34(2):165-75
pubmed: 16844795
J Behav Health Serv Res. 2015 Oct;42(4):417-36
pubmed: 24595815
Med J Aust. 2007 Oct 1;187(7):387-90
pubmed: 17908000

Auteurs

Jennifer E Johnson (JE)

Michigan State University College of Human Medicine, 200 East 1(st) St Room 366, Flint, MI 48503, United States of America. Electronic address: JJohns@msu.edu.

Richard Jones (R)

Brown University Warren Alpert Medical School, 700 Butler Drive, Providence, RI 02906, United States of America. Electronic address: Richard_Jones@brown.edu.

Ted Miller (T)

Pacific Institute for Research and Evaluation, 11720 Beltsville Drive, Suite 909, Calverton, MD 20705, United States of America. Electronic address: Miller@pire.org.

Ivan Miller (I)

Brown University Warren Alpert Medical School, 345 Blackstone Blvd, Providence, RI 02906, United States of America. Electronic address: Ivan_Miller_iii@brown.edu.

Barbara Stanley (B)

Columbia University, 1051 Riverside Drive, Unit 42, New York, NY 10032, United States of America. Electronic address: Bhs2@columbia.edu.

Greg Brown (G)

University of Pennsylvania Perelman School of Medicine, 3535 Market Street, Room 2032, Philadelphia, PA 19104, United States of America. Electronic address: gregbrow@mail.med.upenn.edu.

Sarah A Arias (SA)

Brown University Warren Alpert Medical School and Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, United States of America.

Louis Cerbo (L)

Rhode Island Department of Corrections, 1375 Pontiac Avenue, Cranston, RI 029020, United States of America. Electronic address: Louis.Cerbo@bhddh.ri.gov.

Julie Rexroth (J)

Genesee County Jail and Corizon Health, 1002 South Saginaw Street, Flint, MI 48502, United States of America. Electronic address: Julie.Rexroth@corizonhealth.com.

Holly Fitting (H)

The Providence Center, 528 N. Main Street, Providence, RI, 02904, United States of America. Electronic address: hfitting@provctr.org.

Danis Russell (D)

Genesee Health System, 420 West 5(th) Avenue, Flint, MI 48503, United States of America. Electronic address: drussell@ghs.org.

Sheryl Kubiak (S)

Wayne State University School of Social Work, 5447 Woodward Avenue, Detroit, MI 48202, United States of America. Electronic address: spk@wayne.edu.

Michael Stein (M)

Boston University, 715 Albany Street, Talbot Building T2W, Boston, MA 02118, United States of America. Electronic address: mdstein@bu.edu.

Christopher Matkovic (C)

Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, United States of America. Electronic address: Christopher_Matkovic@brown.edu.

Shirley Yen (S)

Brown University Warren Alpert Medical School, 700 Butler Drive, Providence, RI 02906, United States of America. Electronic address: Shirley_Yen_PhD@brown.edu.

Brandon Gaudiano (B)

Brown University Warren Alpert Medical School and Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906, United States of America. Electronic address: Brandon_Gaudiano@brown.edu.

Lauren M Weinstock (LM)

Brown University Warren Alpert Medical School, 700 Butler Drive, Providence, RI 02906, United States of America. Electronic address: Lauren_Weinstock@brown.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH